Company Data
Atossa Therapeutics Inc.
Ticker
ATOS
Current Price
$0.8132 -3.13%
Market Cap
$105.0M
Price Target
Refer to Report
Volume
429.6K
52wk Range
$0.5526 - $1.66
Overview
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company’s drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.